T-cell prolymphocytic leukemia overview: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{T-cell prolymphocytic_leukemia}} {{CMG}} ==Overview== ''T-cell-prolymphocytic leukemia (T-PLL)''' is a mature T-cell leukemia with aggressive behavior and ..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{T-cell prolymphocytic_leukemia}} | {{T-cell prolymphocytic_leukemia}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Revision as of 14:15, 21 September 2012
|
T-cell prolymphocytic leukemia Microchapters |
|
Differentiating T-cell prolymphocytic leukemia historical perspective from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
T-cell prolymphocytic leukemia overview On the Web |
|
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia overview |
|
Risk calculators and risk factors for T-cell prolymphocytic leukemia overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
T-cell-prolymphocytic leukemia (T-PLL)' is a mature T-cell leukemia with aggressive behavior and predilection for blood, bone marrow, lymph nodes, liver, spleen, and skin involvement.[1]
References
- ↑ Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. (eds): World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. IARC Press: Lyon 2001